Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading ->
An independent evaluation of the global response to the coronavirus pandemic, including steps taken by the World Health Organization, will be led by former Prime Minister of New Zealand Helen Clark and former President of Liberia Ellen Johnson Sirleaf. The former world leaders will co-chair and Independent Panel for Pandemic Preparedness and Response (IPPR), the […] Continue reading ->
A growing bloc of aerosol scientists, epidemiologists, and infectious disease experts are urging the World Health Organization to acknowledge that particles containing SARS-CoV-2, the virus that causes COVID-19, can remain suspended in the air for hours and be inhaled, potentially representing another route of transmission. Some 239 scientists from around the world urged the WHO […] Continue reading ->
Access to life-saving dexamethasone will be expanded to some 4.5 million COVID-19 patients in low- and middle-income countries through an advance bulk purchase of the drug in bulk, UNITAID has said. The move is the first concrete step by a global health agency under the umbrella of the WHO ACT accelerator partnership to boost access […] Continue reading ->
A landmark meeting hosted next week by the International Energy Agency (IEA) will bring together major powers to debate the key actions for a climate-friendly COVID-19 recovery in an online forum open to public viewing.  The IEA Clean Energy Transitions Summit will be live-streamed July 9th, and bring together the world’s largest economies and developing […] Continue reading ->
A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading ->